NDC 0078-0639
COSENTYX
Secukinumab
COSENTYX is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Secukinumab.
| Product ID | 0078-0639_1b52f8f5-c6db-4d83-ac31-f566d2bf99a4 |
| NDC | 0078-0639 |
| Product Type | Human Prescription Drug |
| Proprietary Name | COSENTYX |
| Generic Name | Secukinumab |
| Dosage Form | Injection |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2015-01-21 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125504 |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | SECUKINUMAB |
| Active Ingredient Strength | 150 mg/mL |
| Pharm Classes | Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
Packaging
NDC 0078-0639-41
2 mL in 1 CARTON (0078-0639-41)
| Marketing Start Date | 2015-01-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0078-0639-97 [00078063997]
COSENTYX INJECTION
| Marketing Category | BLA |
| Application Number | BLA125504 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2015-01-21 |
NDC 0078-0639-68 [00078063968]
COSENTYX INJECTION
| Marketing Category | BLA |
| Application Number | BLA125504 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2015-01-21 |
NDC 0078-0639-98 [00078063998]
COSENTYX INJECTION
| Marketing Category | BLA |
| Application Number | BLA125504 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2015-01-21 |
NDC 0078-0639-41 [00078063941]
COSENTYX INJECTION
| Marketing Category | BLA |
| Application Number | BLA125504 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2015-01-21 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| SECUKINUMAB | 150 mg/mL |
OpenFDA Data
| SPL SET ID: | 77c4b13e-7df3-42d4-81db-3d0cddb7f67a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Pharmacological Class
- Interleukin-17A Antagonist [EPC]
- Interleukin-17A Antagonists [MoA]
NDC Crossover Matching brand name "COSENTYX" or generic name "Secukinumab"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0078-0639 | COSENTYX | secukinumab |
| 0078-1056 | COSENTYX | secukinumab |
Trademark Results [COSENTYX]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 COSENTYX 86734365 4979935 Live/Registered |
Novartis AG 2015-08-24 |
 COSENTYX 85804029 4716891 Live/Registered |
Novartis AG 2012-12-17 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.